Home › NDC Lookup › RxCUI directory › RxCUI 2534871

Ephedrine hydrochloride 12.5 MG Oral Tablet — RxCUI 2534871

RxNorm drug concept · Semantic clinical drug
RxCUI 2534871 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2534871
Official nameEphedrine hydrochloride 12.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asephedrine HCl 12.5 MG Oral Tablet
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ephedrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Some ephedrine-containing asthma tablets, like Bronkaid and Primatene, are available over the counter, but there's an important catch: you should only use them if a doctor has alre...
  • I have asthma — can I just pick up ephedrine tablets at the pharmacy without a prescription?
  • The biggest things to watch for are a rapid heartbeat, tremors, severe nervousness, trouble sleeping, or difficulty breathing that isn't improving. Because ephedrine raises your bl...
  • What should I watch out for when taking the asthma tablets?
📖 Read our full Ephedrine guide →

🕸️ Concept Web — How Ephedrine hydrochloride 12.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ephedrine hydrochloride 12.5 MG Oral Tablet RxCUI 2534871

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ephedrine 3966
    • Ephedrine hydrochloride 91165
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Primatene with ephedrine 2591365
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ephedrine Oral Tablet 372020
    • Ephedrine hydrochloride Oral Tablet 2648577
    • Ephedrine Oral Product 1163315
    • Ephedrine Pill 1163874
    • Ephedrine hydrochloride Oral Product 2661947
    • Ephedrine hydrochloride Pill 2661823
    • Ephedrine Oral Tablet [Primatene with ephedrine] 2591389
    • Ephedrine hydrochloride Oral Tablet [Primatene with ephedrine] 2654924
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ephedrine hydrochloride 12.5 MG SCDC · 1115988
  • Ephedrine Oral Tablet SCDF · 372020
  • Ephedrine hydrochloride Oral Tablet SCDFP · 2648577
  • Ephedrine Oral Product SCDG · 1163315
  • Ephedrine Pill SCDG · 1163874
  • Ephedrine hydrochloride Oral Product SCDGP · 2661947
  • Ephedrine hydrochloride Pill SCDGP · 2661823

Brand-Name Concepts

  • Ephedrine hydrochloride 12.5 MG Oral Tablet [Primatene with ephedrine] SBD · 2591390
  • Ephedrine hydrochloride 12.5 MG [Primatene with ephedrine] SBDC · 2591386
  • Ephedrine Oral Tablet [Primatene with ephedrine] SBDF · 2591389
  • Ephedrine hydrochloride Oral Tablet [Primatene with ephedrine] SBDFP · 2654924
  • Primatene with ephedrine Oral Product SBDG · 2591387
  • Primatene with ephedrine Pill SBDG · 2591388
  • Primatene with ephedrine BN · 2591365

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 2534871 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-9812-07 4 BLISTER PACK in 1 CARTON (0363-9812-07) / 15 TABLET in 1... Ephedrine Hydrochloride Walgreen Company 2021-12-02
80070-0600-24 2 BLISTER PACK in 1 CARTON (80070-600-24) / 12 TABLET in 1... Primatene Foundation Consumer Brands 2021-01-22
80070-0600-60 5 BLISTER PACK in 1 CARTON (80070-600-60) / 12 TABLET in 1... Primatene Foundation Consumer Brands 2021-01-22
Observed labelers: Foundation Consumer Brands (2) · Walgreen Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.